A Zoloft birth-defect case involving a California-based distributor of the drug should be sent back to that state from the multidistrict litigation based in Philadelphia, the plaintiff has argued.
According to court papers, D.B. v. Pfizer was originally filed in California state court where several cases against pharmaceutical distributor McKesson Corp. have been consolidated. The case was removed by Pfizer to the MDL in the U.S. District Court for the Eastern District of Pennsylvania, claiming that McKesson was fraudulently joined.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
